Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Benchmark raised shares of Emergent BioSolutions from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a report on Monday, April 10th.
Finally, Ancora Advisors LLC acquired a new stake in Emergent BioSolutions in the first quarter valued at approximately $66,000.
Finally, Quantbot Technologies LP acquired a new position in Emergent BioSolutions in the first quarter valued at approximately $117,000.
TheStreet downgraded Emergent BioSolutions from a “c-” rating to a “d” rating in a report on Monday, February 27th.